ChartRow logo
NBIX
Neurocrine Biosciences Inc.Stock · Health Care
$150.80−$5.69 (-3.64%)as of market close, Aug 13, 2026
☾ After hours:$150.82+0.00%3:59 PM ET
CompareLLYUNHJNJABBVISRGTMO

NBIX monthly returns

Neurocrine Biosciences Inc. has averaged 2.17% per month, positive in 51% of months. Month-by-month returns for Neurocrine Biosciences Inc. (NBIX) below, through August 13, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.

Average month
+2.2%
356 months
Best month
+91.0%
Nov 1999
Worst month
-65.6%
May 2006
Positive months
51%
of all months

Neurocrine Biosciences Inc. monthly returns#

Neurocrine Biosciences Inc. total return by month
MonthTotal return
Aug 2026
-9.6%
Jul 2026
-1.0%
Jun 2026
+6.5%
May 2026
+20.2%
Apr 2026
-0.1%
Mar 2026
-0.4%
Feb 2026
-2.8%
Jan 2026
-4.1%
Dec 2025
-6.8%
Nov 2025
+6.2%
Oct 2025
+2.0%
Sep 2025
+0.6%

Monthly total return (since Sep 2021)

-20%-10%+0%+10%+20%
20222023202420252026

Methodology#

Monthly returns are total returns (dividends reinvested), computed from NBIX's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.

See also: S&P 500 · Nasdaq-100 · Dow Jones · Russell 2000 · US Bond Market · Gold · Silver · Bitcoin · Ethereum

FAQ#

What is Neurocrine Biosciences Inc.'s average monthly return?
Neurocrine Biosciences Inc. (NBIX) has averaged about 2.17% per month, positive in roughly 51% of months. The best month was Nov 1999 (+91.0%) and the worst was May 2006 (-65.6%).